A5102916339- Mechanical Circulatory Support Devices
- Glioma Diagnosis and Treatment
- Central Venous Catheters and Hemodialysis
- Radiomics and Machine Learning in Medical Imaging
- Retinal Diseases and Treatments
- Meningioma and schwannoma management
- Hospital Admissions and Outcomes
- Cerebrovascular and Carotid Artery Diseases
- Healthcare Systems and Practices
- Intracranial Aneurysms: Treatment and Complications
- Cardiac Arrest and Resuscitation
- Healthcare Operations and Scheduling Optimization
- Vascular Malformations Diagnosis and Treatment
- Retinal Imaging and Analysis
- Cardiac Structural Anomalies and Repair
- Health, Medicine and Society
- Antioxidants, Aging, Portulaca oleracea
- Appendicitis Diagnosis and Management
- Surgical Sutures and Adhesives
- Orthopaedic implants and arthroplasty
- Scoliosis diagnosis and treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Adolescent and Pediatric Healthcare
- Spinal Fractures and Fixation Techniques
- Abdominal Surgery and Complications
Hospices Civils de Lyon
2013-2024
Université Claude Bernard Lyon 1
2013-2024
Matériaux Ingénierie et Science
2013-2024
Centre National de la Recherche Scientifique
2013-2024
University of Warwick
2016-2024
Hôpital Edouard Herriot
2021-2024
Genetique Reproduction and Developpement
2020
Institut NeuroMyoGène
2016
Inserm
2016
HCL Technologies (India)
2015
There is strong concern about the costs associated with adding tumor-treating fields (TTF) therapy to standard first-line treatment for glioblastoma (GBM). Hence, we aimed determine cost-effectiveness of TTF newly diagnosed patients GBM.We developed a 3-health-state Markov model. The perspective was that French Health Insurance, and horizon lifetime. We calculated transition probabilities from survival parameters reported in EF-14 trial. main outcome measure incremental effectiveness...
<h3>BACKGROUND AND PURPOSE:</h3> Endovascular treatment of wide-neck anterior communicating artery aneurysms can often be challenging. The Woven EndoBridge (WEB) device is a recently developed intrasaccular flow disrupter dedicated to endovascular intracranial aneurysms. aim this study was investigate the feasibility, safety, and efficacy WEB Dual-Layer Single-Layer devices for <h3>MATERIALS METHODS:</h3> Patients with treated between June 2013 March 2014 in 5 French centers were analyzed....
Background Young people (aged 16–24 years) with long-term health conditions tend to disengage from services, resulting in poor outcomes. They are prolific users of digital communications. Innovative UK NHS clinicians use communication these young people. The plans patients more widely. Objectives To explore how health-care engagement can be improved using clinical (DCC); understand effects, impacts, costs and necessary safeguards; provide critical analysis its use, monitoring evaluation....
Background and Aim of the Study Extracorporeal life support (ECLS) may be necessary in refractory postcardiotomy cardiogenic shock (PCS) unresponsive to optimal medical treatment. We sought analyze results temporal outcomes ECLS for PCS. Methods performed an observational analysis our prospective database. In order trends PCS, patients were divided into two groups according period implantation: Group I from January 2007-June 2012, II July 2012-December 2017. The primary endpoint was survival...
What is new and objectives Trends in the care of glioblastoma actual practice settings are poorly described. In a previous pharmacoepidemiologic study, we highlighted changes management patients with (GBM) newly diagnosed between 2004 2008. Our aim was to complete extend report study cohort 2011 emphasize trends pharmacotherapy GBM over last decade. Methods A single-centre undertaken three historic cohorts during years 2004, 2008 (corresponding groups 1, 2 3, respectively) but limited...
What is known and objective Therapeutic options for the management of glioblastoma (GBM) have greatly evolved over last decade with emergence new regimens combining radiotherapy plus temozolomide use bevacizumab at recurrence. Our aim was to assess clinical economic impacts those novel strategies in our center. Methods A single-center retrospective chart review conducted on patients newly diagnosed a GBM two periods (year 2004, group 1 or year 2008, 2) limitations eligible after initial...
Central-venous-line-associated bloodstream infection (CLABSI) is a significant cause of morbidity and mortality in preterm infants. As there large variation the reported effect multi-modal preventive strategies, it could be relevant to propose new additional strategies.
En France, depuis mars 2020, la chirurgie mini-invasive assistée par robot est identifiable dans les bases de données hospitalières grâce aux extensions des codes d'actes chirurgicaux. L'objectif cette étude était réaliser un état lieux du recours à avec assistance (AR) ou sans AR, au sein établissements santé français entre 2020 et 2022 (évolution, distribution géographique caractéristiques patients établissements). Une observationnelle a été conduite partir Système national santé, incluant...
A new medical device was developed for multi-infusion in neonatal intensive care units (NICUs) with the aim of addressing issues related to drug incompatibilities and central-line-associated bloodstream infections (CLABSIs). To assess cost-effectiveness implementing this perfusion system an NICU setting. This single-centre, observational study conducted all infants admitted within 3 days birth, who required a central venous line, evaluate cost effectiveness before (2019) after (2020)...
Background: The pursuit of developing effective drugs as antioxidants can be traced back to herbal ingredients, including purslane (Portulaca oleracea). potential a medicinal herb maximized by selecting the most suitable extraction method and type solvent. Objective: To assess levels total phenolic compounds, flavonoids, radical scavenging capacity in P. oleracea obtained through various methods solvents. Methods: This study combines maceration reflux with 96% ethanol, 80% methanol, methanol...
Le myelome multiple est une hemopathie maligne grave caracterisee notamment par des atteintes osseuses. Pendant plusieurs decennies, la chimiotherapie orale associant melphalan et prednisone a constitue le traitement conventionnel de reference. Dans les annees 1990, intensive avec autogreffe cellules souches peripheriques montre superiorite en terme mortalite rapport au conventionnel. reste cependant pathologie incurable. Recemment, nouvelles molecules (thalidomide, bortezomib, lenalidomide)...